(NASDAQ: AZTA) Azenta's forecast annual revenue growth rate of 5.84% is not forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 11.47%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 55.94%.
Azenta's revenue in 2026 is $593,821,000.On average, 10 Wall Street analysts forecast AZTA's revenue for 2026 to be $28,848,046,544, with the lowest AZTA revenue forecast at $27,598,361,252, and the highest AZTA revenue forecast at $29,896,317,356. On average, 10 Wall Street analysts forecast AZTA's revenue for 2027 to be $30,374,218,984, with the lowest AZTA revenue forecast at $28,589,412,042, and the highest AZTA revenue forecast at $31,626,650,836.
In 2028, AZTA is forecast to generate $32,134,306,876 in revenue, with the lowest revenue forecast at $29,607,928,442 and the highest revenue forecast at $33,933,762,143.